Bafilomycin A1 inhibits SARS-CoV-2 infection in a human lung xenograft mouse model

Coronavirus disease 2019 is a global pandemic caused by SARS-CoV-2. The emergence of its variant strains has posed a considerable challenge to clinical treatment. Therefore, drugs capable of inhibiting SARS-CoV-2 infection, regardless of virus variations, are in urgently need. Our results showed tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Cuiling, Wei, Bingjie, Liu, Zirui, Yao, Wei, Li, Yiquan, Lu, Jing, Ge, Chenchen, Yu, Xiaoyang, Li, Dapeng, Zhu, Yilong, Shang, Chao, Jin, Ningyi, Li, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887234/
https://www.ncbi.nlm.nih.gov/pubmed/36721152
http://dx.doi.org/10.1186/s12985-023-01971-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887234/
https://www.ncbi.nlm.nih.gov/pubmed/36721152
http://dx.doi.org/10.1186/s12985-023-01971-x

Ejemplares similares